We aim to bridge the funding gap for University of Adelaide research that has potential for translation to commercial impact.
Commercial Accelerator Scheme (CAS)
The Commercial Accelerator Scheme is a competitive, internal funding program which provides financial support for early-stage research with potential for commercial application.
Managed by our Commercialisation team, the Scheme funds the development of innovations at all stages of the commercial pipeline to the point where they can be commercialised as new products, services and companies (this is not funding for basic research).
To apply, please speak to your Commercial Manager or contact us on: email@example.com
Other funding sources
In addition to our internal funding scheme, there are a number of external funding sources for research commercialisation. Our Commercial Managers can assist researchers in accessing this funding.
The University of Adelaide, along with the other Group of Eight Universities and the University of Auckland are exclusive beneficiaries in a $200m venture fund established by the IP Group.
The IP Group works in partnership with the University to identify ground-breaking technologies which have the most promising commercial potential. We work together to develop and form spin-out companies, which they support with capital and expertise to create significant value for all stakeholders.
As a priority investment partner, the University is required to present IP Group with all new unencumbered invention disclosures and provide IP Group with a first right of refusal. Early notification is highly encouraged.
If you are interested in presenting a technology to the IP Group, please:
Medical Research Commercialisation Fund (MRCF)
The Medical Research Commercialisation Fund (MRCF), managed by Brandon Capital, is an innovative investment collaboration which invests in life science opportunities from its member medical research institutes and their associated hospitals throughout Australia.
The MRCF has $200m of funding available from Australian superannuation funds, to invest in early stage technologies. The Fund also provides valuable commercialisation advice to its 50 member institutes.
The Robinson Research Institute is the University of Adelaide’s member institute for the fund. Projects considered for funding by the MRCF need to show a benefit back to the Robinson Research Institute.
Contact Jeremy Thompson, the University’s MRCF representative, for more information.